Search

Your search keyword '"PATENT law"' showing total 7 results
Start Over Descriptor "PATENT law" Topic health Publisher plus media solutions
7 results on '"PATENT law"'

1. Blockchain Holdings Blockchain Holdings Update

Subjects
London Stock Exchange PLC -- Officials and employees, Quarantine, Securities industry -- Officials and employees, Stock offerings, Stock exchanges, World health, Technology, Health, Patent law, Publicly held corporations, Securities industry, General interest, News, opinion and commentary
Abstract

London: London Stock Exchange plc has issued the following announcement: March 20, 2020 - Blockchain Holdings Ltd. ('Blockchain') (CSE:BCX), a public company listed on the Canadian Securities Exchange under the [...]

Published
2020

2. Inventor Of 'LessDrops,' Surgical Eyedrop, Wins Return Of Patent From Harrow Health

Subjects
Pharmaceuticals Inc. -- Intellectual property, Patents, Infection control, Marketing, Intellectual property, Infection, Health, Production management, Patent law, Novels, Patent/copyright issue, General interest, News, opinion and commentary
Abstract

ROSELAND: NOVEL DRUG SOLUTIONS has issued the following press release: Novel Drug Solutions, LLC and Eye Care Northwest, PA, announce the return of their unrestricted patent rights to several awarded [...]

Published
2019

3. Swiss Official Gazette of Commerce notice: HR of the canton of Nidwalden: Deletion OPTERION Health AG, Stansstad HR03-1004703236

Subjects
Intellectual property, Medical supplies, Technology, Intellectual property law, Pharmaceutical industry, Trademarks, Health, Patent law, Intellectual property, General interest, News, opinion and commentary
Abstract

Bern: Swiss Official Gazette of Commerce has issued the following notice: Deletion OPTERION Health AG, Stansstad Spichermatt 7 6365 Kehrsiten Legal form: Purpose The purpose of the company is the [...]

Published
2019

4. Federal Court of Australia decision: InterPharma Pty Ltd v Hospira, Inc [2017] FCA 1075 (11 September 2017)

Subjects
Australia. Federal Court of Australia, Orion Corp., Apple Inc., Hospira Inc., Australian Broadcasting Corp., Samsung Electronics Company Ltd., Television broadcasting industry -- International economic relations, Dexmedetomidine, Industrial equipment industry -- International economic relations, Consumer electronics industry -- International economic relations, Pharmaceutical industry -- International economic relations, Computer industry -- International economic relations, Patent law, Generic drugs, Health, Consumer electronics industry, Microcomputer industry, Computer industry, News, opinion and commentary, Precedex (Medication)
Abstract

Canberra: Federal Court of Australia has issued the following decision on (11 September 2017): FEDERAL COURT OF AUSTRALIA InterPharma Pty Ltd v Hospira, Inc [2017] FCA 1075 File number: VID [...]

Published
2019

5. 'Lifesaving' Breakthrough in Viziblezone's 'Hidden Pedestrian' Detection System for Self-driving Cars

Subjects
Traffic accidents, Driverless cars, Detection equipment, Cyclists, Accidents, Technology, Health, Public health, Patent law, General interest, News, opinion and commentary
Abstract

JERUSALEM: Viziblezone has issued the following press release: Viziblezone, the provider of the first ready-to-launch 'vehicle-to-pedestrian' (V2P) solution, announced today that its patent-protected pedestrian detector technology successfully completed a major [...]

Published
2019

6. Federal Court of Australia decision: Bayer Pharma Aktiengesellschaft v Generic Health Pty Ltd [2017] FCA 428 (4 May 2017)

Subjects
Australia. Federal Court of Australia, Bayer Australia Ltd. -- Intellectual property, Health, Generic drugs, Patent infringement, Pharmaceutical industry -- Intellectual property, Patent law, News, opinion and commentary
Abstract

Canberra: Federal Court of Australia has issued the following decision on (4 May 2017): FEDERAL COURT OF AUSTRALIA Bayer Pharma Aktiengesellschaft v Generic Health Pty Ltd [2017] FCA 428 File [...]

Published
2019

7. Axcella Announces Patent Issuance for AXA Candidate AXA1125

Subjects
Patent law, Trademarks, Biotechnology industries, Patents, Health, Novels, Industrial research, General interest, News, opinion and commentary
Abstract

CAMBRIDGE, Mass: Axcella Health has issued the following press release: Axcella Health, a biotechnology company pioneering the research and development of novel multifactorial interventions to address dysregulated metabolism and support [...]

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results